Table 2 Descriptive data, response to treatment, and recurrence rates of the groups
GROUP 3 (n = 21) | GROUP 4 (n = 23) | p | |
|---|---|---|---|
Age (years) (median, min–max) | 7 (6–12) | 7 (6–13) | 0.708 |
Gender (M/F) | 11/10 | 11/12 | 0.765 |
Symptom severity (moderate/severe) | 11/10 | 13/10 | 0.559 |
Pre-treatment number of wet nights (median, min–max) | 6 (3–7) | 5 (3–7) | 0.569 |
Pre-treatment daily screen time (median, min–max)—mins | 135 (90–210) | 126 (68–185) | 0.532 |
Post-treatment daily screen time (median, min–max)—mins | 52 (30–60) | 120 (76–180) | < 0.001 |
Full response to treatment %(n) | 70% (14/20) | 31% (5/16) | 0.021 |
Failure of treatment %(n) | 5% (1/21) | 30% (7/23) | 0.048 |
Recurrence %(n) | 7% (1/14) | 60% (3/5) | 0.037 |